Sanofi (SNY) Receivables - Other (2015 - 2025)

Sanofi (SNY) has 11 years of Receivables - Other data on file, last reported at $684.5 million in Q4 2025.

• Quarterly Receivables - Other rose 248.11% year-over-year to $684.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $684.5 million (up 248.11% YoY) and the FY2025 annual result came in at $684.5 million, up 248.11% from the prior year.
• Receivables - Other advanced to $684.5 million in Q4 2025 per SNY's latest filing, from $196.6 million in the prior quarter.
• The five-year high for Receivables - Other was $1.6 billion in Q4 2023, with the low at $196.6 million in Q4 2024.
• Average Receivables - Other over 5 years is $739.3 million, with a median of $684.5 million recorded in 2025.
• Year-over-year, Receivables - Other soared 1444.75% in 2021 and sank 87.38% in 2024.
• Sanofi's Receivables - Other stood at $920.9 million in 2021, then slumped by 63.44% to $336.7 million in 2022, then jumped by 362.74% to $1.6 billion in 2023, then plunged by 87.38% to $196.6 million in 2024, then jumped by 248.11% to $684.5 million in 2025.
• Business Quant data shows SNY's Receivables - Other at $684.5 million in Q4 2025, $196.6 million in Q4 2024, and $1.6 billion in Q4 2023.